| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0022 | 1 |